REMEGEN(09995),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

09995 REMEGEN

Not Yet Opened 09-01 16:08:13

79.350

-1.350

-1.67%

High80.950	Low78.800	Vol1.99M
Open80.950	D1 Closing80.700	Amplitude2.66%
Mkt Cap44.72B	Tradable Cap16.55B	Total Shares563.61M
T/O158.03M	T/O Rate0.95%	Tradable Shares208.58M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"09995","market":"HK","secType":"STK","nameCN":"REMEGEN","latestPrice":79.35,"timestamp":1788250093010,"preClose":80.7,"halted":0,"volume":1988117,"delay":0,"changeRate":-0.01672862453531609,"floatShares":208581239,"shares":563608243,"eps":1.5045448343996985,"marketStatus":"Not Yet Opened","change":-1.35,"latestTime":"09-01 16:08:13","open":80.95,"high":80.95,"low":78.8,"amount":158028830,"amplitude":0.026642,"askPrice":79.35,"askSize":2000,"bidPrice":79.25,"bidSize":500,"shortable":3,"etf":0,"ttmEps":12.113841567855347,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788312600000},"marketStatusCode":0,"adr":0,"listingDate":1604851200000,"exchange":"SEHK","adjPreClose":80.7,"openAndCloseTimeList":[[1788226200000,1788235200000],[1788238800000,1788249600000]],"volumeRatio":0.49047999328438624,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688331","market":"SH","secType":"STK","nameCN":"Remegen Co.,Ltd.","latestPrice":119.65,"timestamp":1788246000000,"preClose":121.78,"halted":0,"volume":4063700,"delay":0,"premium":"-43.14"}},"requestUrl":"/m/hq/s/09995/tweets","defaultTab":"tweets","newsList":[{"id":"1119974337","title":"Executive Director Wang Yuxiao Reduces Stake in Remegen with Share Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=1119974337","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119974337?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:44","pubTimestamp":1788263056,"startTime":"0","endTime":"0","summary":"Hong Kong Exchange records show that on August 26, Executive Director Wang Yuxiao sold 6,500 shares of Remegen (09995) at an average price of HK$82 per share, totaling HK$533,000.Following the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EWH","BK1161","LU2328871848.SGD","LU1064130708.USD","688331","09995","LU1969619763.USD","LU2488822045.USD","LU2148510915.USD","LU1064131003.USD","BK1574","BK1583","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662184712","title":"RemeGen (SEHK:9995) Stock Profit Surge Meets Doubts Over Earnings Durability","url":"https://stock-news.laohu8.com/highlight/detail?id=2662184712","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662184712?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:43","pubTimestamp":1787741007,"startTime":"0","endTime":"0","summary":"RemeGen stock closed at HK$80.40 on Wednesday, only slightly higher over the past week, even as the latest earnings landed with a jolt. The headline is simple: profitability in Q2 looks striking on paper, with basic earnings per share of ¥7.81 driven by net income of ¥4,334.28m. Yet the stock still trades on a trailing P/E of 6.6x while Hong Kong biotech peers sit far higher. The sentiment gap today relates to investors questioning how much of that earnings power is durable and how much the...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9995/remegen-shares/news/remegen-sehk9995-stock-profit-surge-meets-doubts-over-earnin","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9995/remegen-shares/news/remegen-sehk9995-stock-profit-surge-meets-doubts-over-earnin","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["JOYT","LU1969619763.USD","DECU","LU2328871848.SGD","GXDW","BK1161","PMDE","VOTE","RGLO","09995","FEBU","BK1574","VGFPF","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120378751","title":"Citi Lifts REMEGEN Price Target to HK$127.7, Keeps Buy/High-Risk Call","url":"https://stock-news.laohu8.com/highlight/detail?id=1120378751","media":"Stock News","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120378751?lang=en_us&edition=fundamental","pubTime":"2026-08-26 17:16","pubTimestamp":1787735782,"startTime":"0","endTime":"0","summary":"Citi has issued a research report highlighting that REMEGEN (09995) posted a 433% year-on-year revenue surge in the first half, swinging to a profit of RMB 4.66 billion. Management noted that...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0170899867.USD","LU1366192091.USD","LU1791807156.HKD","LU0648001328.SGD","LU1162221912.USD","LU1969619763.USD","C","LU0098860793.USD","LU0106831901.USD","BK4207","LU2328871848.SGD","LU0130102774.USD","LU2488822045.USD","LU2456880835.USD","BK4566","688331","LU1267930227.SGD","LU1064130708.USD","BK1583","LU0310800965.SGD","LU0314106906.USD","BK4534","LU0128525689.USD","LU2148510915.USD","LU2236285917.USD","LU1668664300.SGD","LU0980610538.SGD","FTXO","LU1244550221.USD","BK0239","LU1506573853.SGD","LU2125154935.USD","BK1574","TFNS","LU1144417596.USD","EWH","LU0130517989.USD","LU1201861249.SGD","LU0203345920.USD","LU1074936037.SGD","IE00BSNM7G36.USD","LU0052756011.USD","LU0203347892.USD","LU0320765646.SGD","LU1244550494.USD","LU2360032135.SGD","BK4559","LU2462157665.USD","LU0477156953.USD","BK1161","LU2125154778.USD","BK4585","09995","LU2417539215.USD","IYF","LU1244550577.SGD","LU1064131003.USD","LU0162691827.USD","LU0072461881.USD","BK4588","BK4504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155760828","title":"CLSA Raises REMEGEN Price Target to HK$144.8, Reiterates Outperform Rating on Strong Q2 Beat","url":"https://stock-news.laohu8.com/highlight/detail?id=1155760828","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155760828?lang=en_us&edition=fundamental","pubTime":"2026-08-26 16:28","pubTimestamp":1787732904,"startTime":"0","endTime":"0","summary":"CLSA has released a research report highlighting that REMEGEN (09995) delivered a remarkable 808.6% year-on-year sales growth in the second quarter of 2026, reaching a net profit of RMB 4.334...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","LU1969619763.USD","LU2488822045.USD","BK1583","LU1064130708.USD","LU1064131003.USD","LU2328871848.SGD","BK0239","09995","LU2148510915.USD","BK1161","EWH","688331"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136334991","title":"HK Movers | Biotech Stocks Jump. CANSINOBIO Surges 17%; Innovent Bio up 11%; Akeso up over 8%; Everest Med up 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1136334991","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136334991?lang=en_us&edition=fundamental","pubTime":"2026-08-26 09:47","pubTimestamp":1787708820,"startTime":"0","endTime":"0","summary":"Biotech stocks jumped in Hong Kong market. CANSINOBIO surged 17%; Innovent Bio up 11%; Akeso up over 8%; Everest Med up 7%.On the news front, $CANSINOBIO(06185)$ announced on August 25 that its...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"330240692f324d079ccf839d9e4180bf","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","02359","06606","09966","02137","02269","09606","03759","01672","03347","09995","02268","09688"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109345562","title":"Movement Alert｜REMEGEN Rises 5.04% in Regular Trading, Interim Results Turn Profitable Amid Biotech Sector Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=1109345562","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109345562?lang=en_us&edition=fundamental","pubTime":"2026-08-26 09:39","pubTimestamp":1787708365,"startTime":"0","endTime":"0","summary":"On August 26, REMEGEN rose 5.04% in regular trading, trading at HK$83.7/share, with turnover of HK$86.20 million.On the news front, the company disclosed its interim report on August 24, reporting...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"REMEGEN Soars on AbbVie Deal Profit Turnaround","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102179577","title":"Market Sentiment Stabilizes as Sanctions Prove Largely Symbolic; Tech Benchmarks Surge on Potential Dovish Fed Signals","url":"https://stock-news.laohu8.com/highlight/detail?id=1102179577","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102179577?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:03","pubTimestamp":1787659392,"startTime":"0","endTime":"0","summary":"Market dynamics took a surprising turn today as the harsh \"devastating\" sanctions threatened by the U.S. yesterday turned out to be more bark than bite. A-shares closed higher while Hong Kong stocks...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2244417387.USD","LU2360107168.USD","BK4612","06821","SG9999015978.USD","SHOC","IE00BKVL7J92.USD","SG9999017495.SGD","LU2236285917.USD","NVD2.UK","LU1712237335.SGD","LU2097344357.USD","LU0128525929.USD","LU2250418816.HKD","LU2746668461.USD","LU0109392836.USD","LU0348814723.USD","LU0786609619.USD","LU1794554557.SGD","LU1868837300.USD","HK0000304805.HKD","LU0819121731.USD","LU1934455194.USD","LU0173614495.USD","LU2452424414.USD","LU1188198961.HKD","LU0314109678.HKD","LU1551013342.USD","BABA","LU1868837136.USD","LU1815333072.USD","LU2087621335.USD","LU0516422952.EUR","LU0345768740.USD","LU2746668974.SGD","LU0061474705.USD","HK0000320264.USD","LU0229945570.USD","LU1720051017.SGD","IE00B4YYXB79.USD","LU2237957902.USD","SG9999000418.SGD","LU0267386448.USD","LU0417517546.SGD","LU1400636491.USD","LU0225283273.USD","LU1496350502.SGD","LU0154236417.USD","ONLN","LU0128525689.USD","LU0265550359.USD","LU2039709279.SGD","IE0004445239.USD","FAI","AGOX","LU0067412154.USD","LU2125909759.SGD","LU0488056044.USD","THMR","SGXZ23171101.USD","LU0708995583.HKD","LU0052750758.USD","LU2471134523.USD","BK4592","01548","LU1267930490.SGD","LU2491050071.SGD","LU2458330243.SGD","BK4220","LU1066051811.HKD","LU1202635105.USD","IE00B1BXHZ80.USD","LU1066053197.SGD","LU0444973449.USD","LU0942090050.USD","LU0353189680.USD","IE00BJLML261.HKD","LU0651947912.USD","LU2237443465.HKD","LU1861127337.USD","LU2125909593.SGD","3NVD.UK","LU2592432038.USD","LU0061475181.USD","LU2065171311.SGD","SG9999002232.USD","SG9999018865.SGD","TRFK","BK1161","LU1969619763.USD","LU1923623000.USD","IE00B0JY6N72.USD","LU1115378108.SGD","LU1852331112.SGD","LU2133065610.SGD","BABX","LU0328353924.USD","IE00BZ199S13.USD","LU1880398471.USD","LU0630378429.USD","LU1069344957.HKD","BK4503","LU0157215616.USD","LU1791710582.SGD","LU0082616367.USD","89888","LU2237443622.USD","XLK","METV","LU0444971666.USD","LU1548497426.USD","LU0323591593.USD","LU0316494557.USD","LU2083900584.USD","BK1170","BK4598","IE00B775SV38.USD","BK1521","BK1609","LU2187417386.USD","LU2361044865.SGD","NVDD","IE000KEQY171.SGD","LU0342679015.USD","LU2092937148.SGD","LU1688375341.USD","SGXZ81514606.USD","LU0056508442.USD","IE0003U64NQ7.SGD","LU1515016050.SGD","SG9999002463.SGD","BK4587","LU2242650005.HKD","SG9999004220.SGD","LU0456827905.SGD","BK1618","LU1839511570.USD","BABW","HK0000306685.HKD","LU1003077747.HKD","LU2351347302.SGD","LU2896262040.SGD","IE00BK4W5M84.HKD","LU0787776722.HKD","LU2168564065.EUR","LU2028103732.USD","BK4526","LU1023057109.AUD","09988","LU0320764599.SGD","BK1506","IE00B19Z9505.USD","WISE","LU2290526834.HKD","NVII","LU0158827948.USD","LU2476274308.USD","SG9999014575.USD","LU1988902786.USD","IE00BMPRXN33.USD","BK4534","LU2552382215.SGD","NULC","IE00BQXX3C00.GBP","IE00B775H168.HKD","LU1048596156.SGD","BK1516","BK4607","LU0327786744.USD","SG9999002224.SGD","BK4585","LU0494093205.USD","LU2125154778.USD","LU1935042991.SGD","LU2461242641.AUD","IE00B1XK9C88.USD","LU0831093199.SGD","BK4543","LU0079474960.USD","LU0072913022.USD","NVDQ","VGT","LU0287142896.SGD","LU0726765562.USD","SG9999015952.SGD","LU0882574139.USD","LU2506951792.HKD","BK4505","AIFD","01057","IE00BK4W5L77.USD","SPTE","BK1589","BK4529","NVDO","LU2756315664.SGD","IE00B3SWFQ91.USD","LU0070217475.USD","LU2264538146.SGD","SG9999014559.SGD","LU0164865239.USD","IE000Q6AESB8.SGD","LU1831875114.USD","LU2471134952.CNY","2NVD.UK","LU2778985437.USD","LU0345770308.USD","SG9999006597.SGD","LU1814569148.SGD","LU1084165304.USD","SGXZ31699556.SGD","LU3063872942.SGD","LU2265009873.SGD","LU1571399168.USD","LU2488822045.USD","LU1144417596.USD","BK4581","LU1267930730.SGD","LU0964807845.USD","LU1674673691.USD","BK1132","BK4575","KBDCY","LU2023250504.SGD","IE00B3M56506.USD","LU2413666426.HKD","LU1282649810.SGD","LU0210533765.USD","LU0051755006.USD","LU1366333091.USD","BIDU","LU1868836914.USD","LU2357125470.USD","601869","LU0943347566.SGD","LU2125154935.USD","LU0572944931.SGD","IE00BDRTCR15.USD","LU2750360997.AUD","CMAG","LU0077335932.USD","BK4533","AIPI","LU1769817096.USD","LU2272731600.USD","LU1051769294.HKD","LU2347655073.USD","ANV","LU1119994496.HKD","LU0215105999.USD","NVDU","LU0289960550.SGD","LU0107464264.USD","BK4550","LU2191332357.HKD","00148","LU2505996509.AUD","NVDS.UK","CNEQ","LU2637965513.SGD","LU0463099449.HKD","LU1235294995.USD","LU2999663052.SGD","IE00BKPKM429.USD","LU1116320737.USD","LU0096364046.USD","SNVDAmain","LU0061474960.USD","LU2237443549.SGD","IETC","LU0323240290.USD","LU1066051498.USD","LU2430703178.SGD","LU0472753341.HKD","SGXZ51526630.SGD","LU2473716301.USD","LU0708994859.HKD","IXN","LU2213496289.HKD","LU0072462343.USD","LU1992135472.HKD","LU1813983027.USD","LU0228367735.SGD","LU0238689110.USD","LU2471134879.HKD","BK4527","LU0052756011.USD","HK0000320223.HKD","LU0918141887.USD","LU2491050154.USD","LU0289739343.SGD","CHPX","IE00BF5LJ272.USD","LU0347712357.USD","LU0163747925.USD","LU1328615791.USD","LU2054465674.USD","LU0227179875.USD","LU1992135399.USD","LU0640798160.USD","LU1989764664.SGD","LU0315179316.USD","LU0395794307.EUR","LU1069347547.HKD","LU1914381329.SGD","NVD3.UK","LU0197773160.USD","LU0820562030.AUD","LU1261432733.SGD","BK1615","LU0528227936.USD","LU0276348264.USD","LU1035773651.USD","LU2430703251.USD","NVYY","LU1037948897.HKD","LU0244354667.USD","01952","LU0011850046.USD","LU2322448957.HKD","LU0683600562.USD","IE00BYXW3230.USD","LU0106959298.USD","LU1815336760.USD","BK4608","LU1989772923.USD","BK1576","SMH","LU1721428933.USD","LU0868494617.USD","LU0256863811.USD","LU0965508806.USD","SG9999014542.SGD","LU0823426480.USD","LU1934455277.USD","ESUM","LU1791710400.SGD","LU1979441026.SGD","LU2420271590.USD","LU2279689827.SGD","LU1951200564.SGD","LU0006306889.USD","LU0251143458.SGD","BK1523","IE00BN29S564.USD","LU1861215975.USD","LU1989764748.USD","BK1574","02269","LU1400636657.SGD","LU0203202063.USD","LU2462157665.USD","LU0081259029.USD","BK1509","LU1917777945.USD","LU0823421333.USD","USD","BK1095","LU2168563687.JPY","GB00BDT5M118.USD","LU0651946864.USD","LU1868836591.USD","BK4614","LU0265550946.USD","BK4588","LU1211504680.USD","LU2381873111.SGD","LU3102509885.SGD","IE00B4JS1V06.HKD","BK1596","IE000YTNTUN2.SGD","FPA","LU0823434583.USD","LU2750360641.GBP","SG9999001424.SGD","LU2226246903.HKD","IE00BWXC8680.SGD","IE00BFSS7M15.SGD","LU0456842615.SGD","SNPE","SGXZ99366536.SGD","USXF","LU0203201768.USD","LU1267930227.SGD","NVDW","LU0823426308.USD","LU0080751232.USD","LU1645745479.HKD","LU0127658192.USD","TYLG","SG9999014880.SGD","BK4524","LU2097344431.USD","LU1691799644.USD","BK1191","LU2929501877.USD","LU2237438978.USD","LU0856984785.SGD","HK0000306701.USD","LU1242518857.USD","NVDX","SOXQ","LU1718418525.SGD","LU0949170772.SGD","LU0795875169.SGD","NVDB","NVDS","ALBmain","SG9999014898.SGD","LU0323239441.USD","BK4538","LU1282648689.USD","BK4535","LU0256863902.USD","CLIX","LU2860962120.EUR","LU0384037296.USD","LU1316542783.SGD","LU0795875086.SGD","LU0310800965.SGD","IE0004086264.USD","LU0138981039.USD","LU0210536198.USD","LU0234572021.USD","LU0354030438.USD","BK4579","LU0308772762.SGD","LU2237443382.USD","LU0724617625.USD","LU0175139822.USD","BK4141","SG9999014906.USD","BK1519","IE00BFSS8Q28.SGD","LU0630378692.HKD","IE00BMPRXR70.SGD","LU0553294199.USD","HK0000304797.USD","CLSE","IE0034224299.USD","LU2756315318.SGD","IE0034235303.USD","LU2168564222.USD","LU1935042488.USD","LU0868494708.USD","01316","SMHX","LU2087625088.SGD","SG9999015358.SGD","BK4567","LU2463028550.USD","LU0543330566.HKD","LU2931357623.SGD","LU0348735423.USD","LU2242649171.HKD","BK1518","LU0029864427.USD","LU0531971595.HKD","BK4558","LU0109391861.USD","LU0501845795.SGD","BK4551","LU2394011477.USD","NVDG","IE00B5TLWC47.USD","SG9999015341.SGD","IE00BZ1G4Q59.USD","IE00BD6J9T35.USD","LU2063271972.USD","LU0359201612.USD","06869","LU1232071149.USD","LU2462591350.SGD","IE0004445015.USD","LU2552382132.HKD","LU1803068979.SGD","SGXZ80539844.SGD","LU2047632596.USD","LU2237443895.HKD","LU1035775433.USD","TEK","LU1244550494.USD","MCHS","LU0069063385.USD","LU0348825331.USD","LU0143551892.USD","LU0274383008.USD","LU0762541174.USD","LU1699723380.USD","LU0912757837.SGD","LU1804176565.USD","LU0345769631.USD","LU0047713382.USD","LU2237443978.SGD","IE0034235295.USD","LU0456846285.SGD","LU0289961442.SGD","LU1989772840.SGD","BK1587","IE00B7KXQ091.USD","LU0198837287.USD","LU1551013425.SGD","LU2403377893.USD","07788","002703","LU1323610961.USD","IE0001KFT4U8.USD","LU2148611432.USD","LU2168564149.EUR","WXXWY","IE00BHPRN162.USD","LU0640476718.USD","VT","IE0009G5SDU7.USD","TTEQ","LU2294711713.HKD","NVDA","BK4548","LU1732800096.USD","LU1435385759.SGD","BK4549","LU0251132253.USD","LU0417516902.SGD","LU0354030511.USD","LU0187121727.USD","LU1935043536.SGD","IE0004091025.USD","LU0210528500.USD","LU0871576103.HKD","LU2089284900.SGD","LU2430703095.HKD","LU0174119429.USD","LU1861220033.SGD","LU0516423174.USD","LU2065171402.SGD","LU0181495838.USD","LU0821914370.USD","LU1821325948.USD","LU1633808545.USD","LU0889565833.HKD","LU2023250330.USD","HK0000914660.USD","LU1008478684.HKD","LU0211328371.USD","LU0823434740.USD","SG9999018857.SGD","LU2361044949.HKD","002821","DIPS","LU0149721374.USD","LU0348816934.USD","HK0000819398.USD","LU2108987350.USD","LU1935043023.USD","IE00B19Z8X17.USD","LU2125909247.SGD","LU0588546209.SGD","LU0557290698.USD","IE00B5949003.HKD","IE00BQXX3F31.USD","IE00BQXX3D17.EUR","LU0096362180.USD","LU1935042215.USD","LU2954938101.SGD","SG9999015945.SGD","LU2211815571.USD","LU0353189763.USD","09888","LU0048584097.USD","LU1429558221.USD","LU2491049909.HKD","LU1481107354.HKD","LU2328871848.SGD","ESLG","SG9999014567.USD","LU0957808578.USD","LU1880398554.USD","02268","IE00BJTD4V19.USD","LU1629891620.HKD","IE00BMPRXQ63.HKD","GAMR","LU1670756490.USD","LU1720050803.USD","LU0320765059.SGD","BK4554","LU1064131342.USD","BK1588","LU1282649067.USD","LU1732799900.SGD","LU1153585028.USD","LU2456880835.USD","LU2089985449.USD","SG9999002562.SGD","01888","LU2347655156.SGD","NVDY","LU0965509101.SGD","BBYY","BK4565","LU2286300806.USD","LU0053666078.USD","BK4605","TCHI","LU1280957306.USD","IE00B3S45H60.SGD","SG9999014914.USD","LU0820561818.USD","LU0511384066.AUD","LU2092627202.USD","09995","LU1127390331.HKD","LU2023251221.USD","LU2065169927.USD","FDTX","BABC","LU0345770993.USD","LU2462591277.SGD","01797","LU1046422090.SGD","LU0823414478.USD","LU0466842654.USD","LU0820561909.HKD","LU1400636574.HKD","IE000ITXATA3.USD","LU0823421416.USD","LU0965509283.SGD","LU2237957811.SGD","LU2168564495.EUR","LU0672654240.SGD","LU0094547139.USD","LU0417516738.SGD","LU0310800379.SGD","ARTY","HK0000532082.HKD","LU0348723411.USD","BK1149","SG9999004303.SGD","LU1105468828.SGD","LU1152091168.USD","LU0043850808.USD","LU2433249047.HKD","IE000W1ABFV2.USD","DRAG","BK1610","IE00BJTD4N35.SGD","LU1951198990.SGD","LU2111349929.HKD","LU0359202008.SGD","LU0197773673.USD","BK4502","BK1575","LU1769817179.HKD","KURE","SOXX","LU0072462426.USD","LU0762542818.HKD","LU1974910355.USD","LU2100268510.USD","LU1923622291.USD","EFIV","LU0211327993.USD","LU1066051225.USD","LU1983260115.SGD","BK4531","BK1141","KBAB","688428","LU2360032135.SGD","LU2089283258.USD","LU0158827781.USD","SNVD.UK","HK0000914686.HKD","LU0648948544.HKD","LU1496350171.SGD","SG9999014674.SGD","LU0307460666.USD","BK1228","TTXU","LU0140636845.USD","LU0965509010.AUD","LU2543165471.USD","BABO","LU2552382058.USD","LU1778281490.HKD","LU0516422440.USD","LU1823568750.SGD","LU0861579265.USD","CHAT","LU2322448791.USD","IE00BDCRKT87.USD","LU0266013472.USD","688331","IE00BKDWB100.SGD","LU2505996681.GBP","LU2602419157.SGD","LU0476273544.USD","LU0345769128.USD","BK4532","BK1144","LU0545039389.USD","BK1583","LU1868836757.USD","LU0516423091.SGD","LU1282649141.HKD","BK4122","LU0797268264.HKD","LU1046421795.USD","LU2458330169.SGD","ILDR","SNVDA2609","LU0788109477.HKD","LU0097036916.USD","LU0823414551.USD","LU1048588211.SGD","LU0310799852.SGD","LU1051768304.USD","LU0689626769.HKD","LU0738911758.USD","LU1366192091.USD","LU1244550577.SGD","LU2249611893.SGD","LU2271345857.HKD","LU0642271901.SGD","LU0133085943.USD","LU1934455863.HKD","LU2106854487.HKD","NVIW.SI","LU0039217434.USD","LU0880133367.SGD","NVD","LU0359201885.HKD","LU2326559502.SGD","IE00B19Z8W00.USD","LU0164880469.USD","LU0211977185.USD","LU0345768153.USD","LU2361045086.USD","LU0985320562.USD","LU2272731865.HKD","LU2357305700.SGD","JGRO","LU1145028129.USD","BK1109","LU0689472784.USD","IE0034235188.USD","07388","LU2247934214.USD","LU1242518931.SGD","02556","LFGY","LU1267930573.SGD","LU0234570918.USD","LU0762540952.USD","IE0009356076.USD","LU0274383776.USD","LU2417539215.USD","LU2413666699.HKD","BK4504","FTEC","IE00BJJMRX11.SGD","SOXY","LU2065170008.USD","NVC","LU1623119135.USD","LU1808992512.USD","SG9999002828.SGD","LU0029874061.USD","LU0128526141.USD","LU2077746001.SGD","LU2471134796.USD","IE00BFMHRM44.USD","LU0918141705.HKD","LU1037948541.HKD","LU0661504455.SGD","LU1152091754.HKD","IE0005OL40V9.USD","LU0708995401.HKD","ABFL","LU1116320901.HKD","LU1244550221.USD","LU0326950275.SGD","LU2360106780.USD","ROM","LU0170899867.USD","IE00BJJMRY28.SGD","LU1880383366.USD","LU0979878070.USD","LU2487616109.SGD","LU0957791311.USD","LU0106261372.USD","LU0124676726.USD","LU1328277881.USD","LU0057025933.USD","LU1674673428.USD","BABU","LU0516422366.SGD","LU1642822529.SGD","NVDL","LU0390134368.USD","LU1923622614.USD","SG9999015986.USD","LU0719512351.SGD","09969","LU1720051108.HKD","LU2125909916.SGD","LU2272731782.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190936744","title":"Movement Alert｜REMEGEN Rises 5.12% in Regular Trading, H1 Earnings Show Turnaround to Profitability with Revenue Surging Over 4x","url":"https://stock-news.laohu8.com/highlight/detail?id=1190936744","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190936744?lang=en_us&edition=fundamental","pubTime":"2026-08-25 09:56","pubTimestamp":1787622992,"startTime":"0","endTime":"0","summary":"On August 25, REMEGEN rose 5.12% in regular trading, trading at HK$77.9/share, with turnover of HK$108 million.On the news front, the company disclosed its half-year report on the evening of August...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"REMEGEN Surges as H1 Revenue Jumps 433% and Returns to Profit","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662026272","title":"RemeGen Swings to Profit in H1 as Revenue Surges Fivefold","url":"https://stock-news.laohu8.com/highlight/detail?id=2662026272","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662026272?lang=en_us&edition=fundamental","pubTime":"2026-08-25 08:36","pubTimestamp":1787618181,"startTime":"0","endTime":"0","summary":"RemeGen  posted an attributable profit of 4.66 billion yuan in the first half of 2026, rebounding from an attributable loss of 449.57 billion yuan a year ago.Earnings per share came in at 8.32 yuan, compared with a loss per share of 0.83 yuan a year earlier, according to a Monday filing with the Hong Kong Exchange.Revenue surged year over year to 5.85 billion yuan from 1.09 billion, the biopharmaceutical company said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["688331","FCA","LU2148510915.USD","BK1574","09995","BK0239","LU1064131003.USD","LU1969619763.USD","BK1161","LU2328871848.SGD","BK1583","LU2488822045.USD","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119855590","title":"RemeGen turns profitable: H1 2026 revenue jumps 435.74% to RMB5.85 billion on AbbVie deal and core drug sales","url":"https://stock-news.laohu8.com/highlight/detail?id=1119855590","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119855590?lang=en_us&edition=fundamental","pubTime":"2026-08-24 22:48","pubTimestamp":1787582902,"startTime":"0","endTime":"0","summary":"RemeGen (09995) reported an unaudited net profit of RMB4.66 billion for the six months ended 30 June 2026, reversing a RMB0.45 billion loss a year earlier. The swing was driven by a quintupled...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"RemeGen turns profitable: H1 2026 revenue jumps 435.74% to RMB5.85 billion on AbbVie deal and core drug sales","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174416927","title":"Movement Alert｜REMEGEN Falls 5.13% in Regular Trading, Market Questions Sustainability of One-Time Licensing Revenue Ahead of Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1174416927","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174416927?lang=en_us&edition=fundamental","pubTime":"2026-08-24 13:08","pubTimestamp":1787548116,"startTime":"0","endTime":"0","summary":"On August 24, REMEGEN fell 5.13% in regular trading, trading at 74.9 HKD/share, with turnover of HKD 184 million. The decline coincided with the board meeting convened to approve interim results for...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"REMEGEN Slumps as One-Time AbbVie Licensing Revenue Sparks Doubt","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138048764","title":"Movement Alert｜REMEGEN Rises 5.2% in Regular Trading, Biotech Sector Rallies Ahead of Interim Results Release","url":"https://stock-news.laohu8.com/highlight/detail?id=1138048764","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138048764?lang=en_us&edition=fundamental","pubTime":"2026-08-20 09:45","pubTimestamp":1787190303,"startTime":"0","endTime":"0","summary":"On August 20, REMEGEN rose 5.2% in regular trading, trading at HK$83.65/share, with turnover of HK$127 million. The stock was lifted by a combination of an imminent mid-term earnings release and...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"REMEGEN Risescas Biotech Sector Rallies Ahead of Interim Results Release","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196300549","title":"RemeGen commits an additional US$30.00 million to OCBC structured deposit; aggregate wealth-management investment reaches US$100.00 million","url":"https://stock-news.laohu8.com/highlight/detail?id=1196300549","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196300549?lang=en_us&edition=fundamental","pubTime":"2026-08-18 20:24","pubTimestamp":1787055878,"startTime":"0","endTime":"0","summary":"RemeGen Co., Ltd. announced that it signed OCBC Wealth Management Product Agreement No. 2 on 18 August 2026 to deploy US$30.00 million of idle self-owned funds into OCBC’s “Zeng Li” Profit-Linked...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143444014","title":"Earning Preview: REMEGEN Q2 revenue is expected to increase by 691%, and institutional views are bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1143444014","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143444014?lang=en_us&edition=fundamental","pubTime":"2026-08-17 08:59","pubTimestamp":1786928360,"startTime":"0","endTime":"0","summary":"Abstract RemeGen Co., Ltd. will release its quarterly results on August 24, 2026 post-Market; based on interim guidance and Q1 disclosures, investors anticipate a licensing-driven step-up in revenue...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Earning Preview: REMEGEN Q2 revenue is expected to increase by 691%, and institutional views are bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152719908","title":"Stock Track | REMEGEN Soars 5.10% Intraday on H1 Profit Turnaround and AbbVie Licensing Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=1152719908","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152719908?lang=en_us&edition=fundamental","pubTime":"2026-08-10 09:48","pubTimestamp":1786326518,"startTime":"0","endTime":"0","summary":"REMEGEN (09995) surged 5.10% during the intraday session on Monday, extending its rally as investors reacted positively to the company's mid-year earnings preview and a lucrative licensing agreement...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127864547","title":"Movement Alert｜REMEGEN Rises 3.88% in Regular Trading, H1 Earnings Preview Shows Turnaround to Profitability with 47 Billion Yuan Net Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=1127864547","media":"Market Focus","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127864547?lang=en_us&edition=fundamental","pubTime":"2026-08-10 09:46","pubTimestamp":1786326404,"startTime":"0","endTime":"0","summary":"On August 10, REMEGEN rose 3.88% in regular trading, trading at 90.5 HKD/share, with turnover of approximately 129 million HKD. The stock continues to benefit from multiple positive catalysts...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133989692","title":"Hong Kong Stocks in Focus: Remegen Surges Over 5% Before Noon, Achieves First Major Mid-Term Profit Driven by Overseas Licensing","url":"https://stock-news.laohu8.com/highlight/detail?id=1133989692","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133989692?lang=en_us&edition=fundamental","pubTime":"2026-08-07 11:56","pubTimestamp":1786074976,"startTime":"0","endTime":"0","summary":"REMEGEN (09995) shares climbed more than 5% in morning trading, reaching 83.95 Hong Kong dollars, with a turnover of 298 million Hong Kong dollars. On the news front, Remegen issued a profit alert,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2148510915.USD","LU1064131003.USD","LU2328871848.SGD","LU2488822045.USD","VXUS","BK1574","688331","BK1583","BK0239","KCAI","BK4585","LU1064130708.USD","BK1161","LU1969619763.USD","BK4588","09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195548946","title":"Movement Alert｜REMEGEN Rises 5.03% in Regular Trading, H1 Earnings Swing to Profit with Essential Drug Catalog Catalyst","url":"https://stock-news.laohu8.com/highlight/detail?id=1195548946","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195548946?lang=en_us&edition=fundamental","pubTime":"2026-08-07 11:22","pubTimestamp":1786072943,"startTime":"0","endTime":"0","summary":"On August 7, REMEGEN rose 5.03% in regular trading, trading at HKD 83.65/share, with turnover of HKD 272 million.On the news front, the company recently disclosed its mid-term earnings forecast,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657062995","title":"RemeGen Expects to Return to Profit in H1; Hong Kong Shares Down 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657062995","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657062995?lang=en_us&edition=fundamental","pubTime":"2026-08-06 12:06","pubTimestamp":1785989213,"startTime":"0","endTime":"0","summary":"RemeGen  expects to return to profit in the first half, estimating a net profit attributable to owners of approximately 4.70 billion yuan, according to a Hong Kong bourse filing on Wednesday.The Chinese pharmaceutical company's Hong Kong shares fell 3% and Shanghai shares rose nearly 3% during the morning trade.The net loss attributable to owners a year earlier was 449.6 million yuan.Operating revenue is expected to surge 433% year on year to 5.85 billion yuan from 1.10 billion yuan.The company attributed the upbeat forecast to the increase in sales revenue from its core products, telitacicept and disitamab vedotin. The agreement with AbbVie for the distribution of RC148 outside China is also expected to generate significantly higher technology licensing revenue.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1064131003.USD","BK1161","LU2148510915.USD","BK1574","LU2488822045.USD","09995","688331","LU1969619763.USD","LU2328871848.SGD","BK0239","BK1583","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159945422","title":"Hong Kong Stock Moves: Remegen Opens Nearly 4% Higher, Anticipates First-Half Net Profit Attributable to Parent of Approximately 4.7 Billion Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1159945422","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159945422?lang=en_us&edition=fundamental","pubTime":"2026-08-06 09:36","pubTimestamp":1785980213,"startTime":"0","endTime":"0","summary":"Remegen (09995) opened nearly 4% higher, and as of the time of writing, it was up 3.94% at HK$85.80, with a turnover of HK$13.6422 million.On the news front, Remegen released its performance...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688331","BK4588","KCAI","LU2328871848.SGD","LU2148510915.USD","BK1574","09995","BK0239","LU1064131003.USD","LU1969619763.USD","BK1161","BK4585","BK1583","LU2488822045.USD","VXUS","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0118},{"period":"1month","weight":-0.0294},{"period":"3month","weight":0.0818},{"period":"6month","weight":0.0319},{"period":"1year","weight":-0.2167},{"period":"ytd","weight":0.1021}],"compareEarnings":[{"period":"1week","weight":-0.0071},{"period":"1month","weight":-0.0214},{"period":"3month","weight":-0.0118},{"period":"6month","weight":0.0003},{"period":"1year","weight":-0.0112},{"period":"ytd","weight":-0.0117}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"RemeGen Co Ltd is a China-based company principally engaged in biopharmaceutical research, biopharmaceutical service, biopharmaceutical production and sale. The Company focuses on therapeutic antibody drugs such as antibody-drug conjugates (ADC), antibody fusion proteins, monoclonal antibodies and bispecific antibodies. The Company’s main products include telitacicept, disitamab vedotin, RC28-E and others. The Company's products are mainly used to treat major diseases such as autoimmune diseases, oncology and ophthalmology. The Company mainly operates its businesses in the domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.110172},{"month":2,"riseRate":0.666667,"avgChangeRate":0.167223},{"month":3,"riseRate":0.5,"avgChangeRate":0.012545},{"month":4,"riseRate":0.833333,"avgChangeRate":0.095268},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.049233},{"month":6,"riseRate":0.666667,"avgChangeRate":0.089626},{"month":7,"riseRate":0.666667,"avgChangeRate":-0.010221},{"month":8,"riseRate":0.333333,"avgChangeRate":0.055035},{"month":9,"riseRate":0.5,"avgChangeRate":0.079897},{"month":10,"riseRate":0.4,"avgChangeRate":0.027845},{"month":11,"riseRate":1,"avgChangeRate":0.038747},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.053467}],"exchange":"SEHK","name":"REMEGEN","nameEN":"REMEGEN"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"REMEGEN(09995),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest REMEGEN(09995) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"REMEGEN,09995,REMEGEN股票,REMEGEN股票老虎,REMEGEN股票老虎国际,REMEGEN行情,REMEGEN股票行情,REMEGEN股价,REMEGEN股市,REMEGEN股票价格,REMEGEN股票交易,REMEGEN股票购买,REMEGEN股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"REMEGEN(09995),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest REMEGEN(09995) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}